Bredewold, O W, Chan, J, Svensson, M, Bruchfeld, A, de Fijter, J W, Furuland, H, Grinyo, J M, Hartmann, A, Holdaas, H, Hellberg, O, Jardine, A, Mjörnstedt, L, Skov, K, Smerud, K T, Soveri, I, Sørensen, S S, Zonneveld, A-J V & Fellström, B 2023, ' Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients : A Randomized Clinical Trial ', Kidney Medicine, vol. 5, no. 1, 100574 . https://doi.org/10.1016/j.xkme.2022.100574 Bredewold, O W, Chan, J, Svensson, M, Bruchfeld, A, Fijter, J W D, Furuland, H, Grinyo, J M, Hartmann, A, Holdaas, H, Hellberg, O, Jardine, A, Mjörnstedt, L, Skov, K, Smerud, K T, Soveri, I, Sörensen, S S, van Zonneveld, A J & Fellström, B 2023, ' Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial ', Kidney Medicine, vol. 5, no. 1, 100574 . https://doi.org/10.1016/j.xkme.2022.100574 Bredewold, O W, Chan, J, Svensson, M, Bruchfeld, A, de Fijter, J W, Furuland, H, Grinyo, J M, Hartmann, A, Holdaas, H, Hellberg, O, Jardine, A, Mjörnstedt, L, Skov, K, Smerud, K T, Soveri, I, Sørensen, S S, Zonneveld, A J V & Fellström, B 2023, ' Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients : A Randomized Clinical Trial ', Kidney Medicine, vol. 5, no. 1, 100574 . https://doi.org/10.1016/j.xkme.2022.100574
Lancet, 393(10184), 1937-1947. Elsevier Limited The Lancet, 393(10184), 1937-1947. Elsevier Lancet, Vol. 393, no. 10184, p. 1937-1947 (2019) LANCET, 393(10184), 1937-1947. ELSEVIER SCIENCE INC Heerspink, H J L, Parving, H-H, Andress, D L, Bakris, G, Correa-Rotter, R, Hou, F-F, Kitzman, D W, Kohan, D E, Makino, H, McMurray, J J V, Melnick, J Z, Miller, M G, Pergola, P E, Perkovic, V, Tobe, S W, Yi, T, Wigderson, M, de Zeeuw, D & Webb, D J 2019, ' Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial ', The Lancet, vol. 393, no. 10184 . https://doi.org/10.1016/S0140-6736(19)30772-X Heerspink, H J L, Parving, H-H, Andress, D L, Bakris, G, Correa-Rotter, R, Hou, F-F, Kitzman, D W, Kohan, D, Makino, H, McMurray, J J V, Melnick, J Z, Miller, M G, Pergola, P E, Perkovic, V, Tobe, S, Yi, T, Wigderson, M, de Zeeuw, D & SONAR Committees and Investigators 2019, ' Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR) : a double-blind, randomised, placebo-controlled trial ', The Lancet, vol. 393, no. 10184, pp. 1937-1947 . https://doi.org/10.1016/S0140-6736(19)30772-X